(CF) CF Industries Holdings - Ratings and Ratios
Ammonia, Urea, Nitric Acid, Ammonium Nitrate, Fertilizer
CF EPS (Earnings per Share)
CF Revenue
Description: CF CF Industries Holdings
CF Industries Holdings, Inc. is a leading manufacturer and distributor of nitrogen and hydrogen products, serving various industries including energy, agriculture, and industrial applications globally. The companys diversified product portfolio includes anhydrous ammonia, granular urea, and urea ammonium nitrate, among others, which are sold through multiple channels to cooperatives, retailers, and industrial users.
From a business perspective, CF Industries operates through multiple segments, including Ammonia, Granular Urea, UAN, AN, and Other, allowing for a granular analysis of its performance across different product lines. The companys product offerings cater to the growing demand for fertilizers, emissions abatement, and industrial applications, positioning it for potential long-term growth.
Key Performance Indicators (KPIs) such as revenue growth, gross margin, and capacity utilization rate are crucial in evaluating CF Industries operational efficiency and financial health. For instance, the companys gross margin can be influenced by factors like production costs, pricing, and sales volume. Additionally, metrics like Return on Equity (RoE) of 26.17% and a forward P/E ratio of 13.79 suggest a relatively strong profitability profile and moderate valuation.
To further analyze CF Industries prospects, it is essential to examine its production capacity, product pricing, and market share, as well as its ability to navigate the cyclical nature of the fertilizers and agricultural chemicals industry. The companys debt-to-equity ratio, interest coverage, and cash flow generation are also important indicators of its financial stability and ability to invest in growth opportunities.
CF Stock Overview
| Market Cap in USD | 13,730m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception | 2005-08-11 |
CF Stock Ratings
| Growth Rating | 20.9% |
| Fundamental | 79.9% |
| Dividend Rating | 73.1% |
| Return 12m vs S&P 500 | -5.21% |
| Analyst Rating | 3.10 of 5 |
CF Dividends
| Dividend Yield 12m | 2.34% |
| Yield on Cost 5y | 6.65% |
| Annual Growth 5y | 10.76% |
| Payout Consistency | 97.9% |
| Payout Ratio | 26.1% |
CF Growth Ratios
| Growth Correlation 3m | -79% |
| Growth Correlation 12m | 29.8% |
| Growth Correlation 5y | 59.7% |
| CAGR 5y | -2.44% |
| CAGR/Max DD 3y | -0.05 |
| CAGR/Mean DD 3y | -0.10 |
| Sharpe Ratio 12m | 2.42 |
| Alpha | -6.83 |
| Beta | 0.985 |
| Volatility | 30.18% |
| Current Volume | 1403.1k |
| Average Volume 20d | 2293.9k |
| Stop Loss | 83 (-3.1%) |
| Signal | 0.06 |
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (1.30b TTM) > 0 and > 6% of Revenue (6% = 386.8m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 11.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.63% (prev 37.46%; Δ -8.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 2.50b > Net Income 1.30b (YES >=105%, WARN >=100%) |
| Net Debt (1.64b) to EBITDA (2.93b) ratio: 0.56 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (163.1m) change vs 12m ago -10.78% (target <= -2.0% for YES) |
| Gross Margin 38.65% (prev 33.28%; Δ 5.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.84% (prev 42.73%; Δ 4.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.15 (EBITDA TTM 2.93b / Interest Expense TTM 154.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.46
| (A) 0.13 = (Total Current Assets 2.68b - Total Current Liabilities 830.0m) / Total Assets 13.75b |
| (B) 0.29 = Retained Earnings (Balance) 3.92b / Total Assets 13.75b |
| (C) 0.15 = EBIT TTM 2.02b / Avg Total Assets 13.76b |
| (D) 0.63 = Book Value of Equity 3.72b / Total Liabilities 5.93b |
| Total Rating: 3.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.87
| 1. Piotroski 8.50pt = 3.50 |
| 2. FCF Yield 11.82% = 5.0 |
| 3. FCF Margin 27.72% = 6.93 |
| 4. Debt/Equity 0.62 = 2.31 |
| 5. Debt/Ebitda 1.05 = 1.70 |
| 6. ROIC - WACC 13.29% = 12.50 |
| 7. RoE 26.14% = 2.18 |
| 8. Rev. Trend -53.30% = -2.66 |
| 9. Rev. CAGR -7.20% = -1.20 |
| 10. EPS Trend -27.57% = -0.69 |
| 11. EPS CAGR 3.03% = 0.30 |
What is the price of CF shares?
Over the past week, the price has changed by +1.36%, over one month by +3.90%, over three months by -8.20% and over the past year by +12.85%.
Is CF Industries Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CF is around 74.10 USD . This means that CF is currently overvalued and has a potential downside of -13.46%.
Is CF a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 18
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 93.6 | 9.3% |
| Analysts Target Price | 93.6 | 9.3% |
| ValueRay Target Price | 82.3 | -3.9% |
Last update: 2025-09-04 04:34
CF Fundamental Data Overview
CCE Cash And Equivalents = 1.69b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 11.1101
P/E Forward = 10.9409
P/S = 2.1297
P/B = 2.8534
P/EG = 0.5429
Beta = 0.923
Revenue TTM = 6.45b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 2.93b USD
Long Term Debt = 2.97b USD (from longTermDebt, last quarter)
Short Term Debt = 98.0m USD (from shortTermDebt, last quarter)
Debt = 3.07b USD (Calculated: Short Term 98.0m + Long Term 2.97b)
Net Debt = 1.64b USD (from netDebt column, last quarter)
Enterprise Value = 15.12b USD (13.73b + Debt 3.07b - CCE 1.69b)
Interest Coverage Ratio = 13.15 (Ebit TTM 2.02b / Interest Expense TTM 154.0m)
FCF Yield = 11.82% (FCF TTM 1.79b / Enterprise Value 15.12b)
FCF Margin = 27.72% (FCF TTM 1.79b / Revenue TTM 6.45b)
Net Margin = 20.20% (Net Income TTM 1.30b / Revenue TTM 6.45b)
Gross Margin = 38.65% ((Revenue TTM 6.45b - Cost of Revenue TTM 3.96b) / Revenue TTM)
Tobins Q-Ratio = 4.06 (Enterprise Value 15.12b / Book Value Of Equity 3.72b)
Interest Expense / Debt = 1.17% (Interest Expense 36.0m / Debt 3.07b)
Taxrate = 16.17% (285.0m / 1.76b)
NOPAT = 1.70b (EBIT 2.02b * (1 - 16.17%))
Current Ratio = 3.22 (Total Current Assets 2.68b / Total Current Liabilities 830.0m)
Debt / Equity = 0.62 (Debt 3.07b / last Quarter total Stockholder Equity 4.96b)
Debt / EBITDA = 1.05 (Net Debt 1.64b / EBITDA 2.93b)
Debt / FCF = 1.72 (Debt 3.07b / FCF TTM 1.79b)
Total Stockholder Equity = 4.98b (last 4 quarters mean)
RoA = 9.47% (Net Income 1.30b, Total Assets 13.75b )
RoE = 26.14% (Net Income TTM 1.30b / Total Stockholder Equity 4.98b)
RoCE = 25.46% (Ebit 2.02b / (Equity 4.98b + L.T.Debt 2.97b))
RoIC = 21.35% (NOPAT 1.70b / Invested Capital 7.95b)
WACC = 8.06% (E(13.73b)/V(16.80b) * Re(9.64%)) + (D(3.07b)/V(16.80b) * Rd(1.17%) * (1-Tc(0.16)))
Shares Correlation 3-Years: -100.00 | Cagr: -1.88%
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.48% ; FCFE base≈1.18b ; Y1≈998.9m ; Y5≈758.1m
Fair Price DCF = 65.96 (DCF Value 10.68b / Shares Outstanding 162.0m; 5y FCF grow -18.69% → 3.0% )
Revenue Correlation: -53.30 | Revenue CAGR: -7.20%
Rev Growth-of-Growth: 45.25
EPS Correlation: -27.57 | EPS CAGR: 3.03%
EPS Growth-of-Growth: 88.53
Additional Sources for CF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle